1
Clinical Trials associated with Allogenic NK cells(Xuzhou Medical University)Early Clinical Study of Allogenic NK Cells (JD002) in Combination With Chemotherapy in the Treatment of Relapsed or Refractory(r/r) Acute Myeloid Leukemia(AML) After Allo-HSCT
This is an open label, single-arm, Phase I study to evaluate the efficacy and safety of allogenic natural killer(NK) cells in subjects with refractory or relapsed AML after allogeneic hematopoietic stem cell transplantation(allo-HSCT). A leukapheresis procedure will be performed to manufacture NK cells. Prior to allogenic NK cells infusion subjects will receive chemotherapy with azacitidine.
100 Clinical Results associated with Allogenic NK cells(Xuzhou Medical University)
100 Translational Medicine associated with Allogenic NK cells(Xuzhou Medical University)
100 Patents (Medical) associated with Allogenic NK cells(Xuzhou Medical University)
100 Deals associated with Allogenic NK cells(Xuzhou Medical University)